[go: up one dir, main page]

AU3240900A - Solid oral dosage form containing heparin or a heparinoid in combination with a carrier - Google Patents

Solid oral dosage form containing heparin or a heparinoid in combination with a carrier

Info

Publication number
AU3240900A
AU3240900A AU32409/00A AU3240900A AU3240900A AU 3240900 A AU3240900 A AU 3240900A AU 32409/00 A AU32409/00 A AU 32409/00A AU 3240900 A AU3240900 A AU 3240900A AU 3240900 A AU3240900 A AU 3240900A
Authority
AU
Australia
Prior art keywords
heparinoid
carrier
combination
dosage form
oral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32409/00A
Inventor
Kenneth Iain Cumming
Mary L. Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emisphere Holdings Inc
Original Assignee
Emisphere Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Technologies Inc filed Critical Emisphere Technologies Inc
Publication of AU3240900A publication Critical patent/AU3240900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU32409/00A 1999-02-22 2000-02-22 Solid oral dosage form containing heparin or a heparinoid in combination with a carrier Abandoned AU3240900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12106599P 1999-02-22 1999-02-22
US60121065 1999-02-22
PCT/US2000/004559 WO2000048589A1 (en) 1999-02-22 2000-02-22 Solid oral dosage form containing heparin or a heparinoid in combination with a carrier

Publications (1)

Publication Number Publication Date
AU3240900A true AU3240900A (en) 2000-09-04

Family

ID=22394277

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32409/00A Abandoned AU3240900A (en) 1999-02-22 2000-02-22 Solid oral dosage form containing heparin or a heparinoid in combination with a carrier

Country Status (2)

Country Link
AU (1) AU3240900A (en)
WO (1) WO2000048589A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
IL126318A (en) 1996-03-29 2004-09-27 Emisphere Tech Inc Compounds and compositions for delivering active agents and some novel carrier compounds
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
ES2242412T3 (en) 1998-07-27 2005-11-01 Emisphere Technologies, Inc. COMPOUNDS THAT ALLOW THE MANAGEMENT OF ACTIVE AGENTS AND COMPOSITIONS BASED ON THESE COMPOUNDS.
US6440929B1 (en) 1998-07-27 2002-08-27 Emisphere Technologies, Inc. Pulmonary delivery of active agents
TR200100366T2 (en) 1998-08-07 2001-11-21 Emisphere Technologies, Inc. Compounds and compositions for dispensing the active substance.
US6991798B1 (en) 1998-08-07 2006-01-31 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
AU4216700A (en) 1999-04-05 2000-10-23 Emisphere Technologies, Inc. Disodium salts, monohydrates, and ethanol solvates
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
US9308220B2 (en) 2001-12-11 2016-04-12 Cosmo Technologies Limited Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
ITMI20012599A1 (en) * 2001-12-11 2003-06-11 Cosmo Spa PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF HEPARINE OR DERIVATIVES, USEFUL FOR THERAPY OF INFLAMMATORY DISEASES OF THE INT
CA2566747C (en) 2004-05-19 2015-04-28 Emisphere Technologies, Inc. Topical cromolyn formulations
MXPA06013295A (en) 2004-05-19 2007-02-22 Emisphere Tech Inc Acyclovir formulations.
CN105708787A (en) 2004-07-12 2016-06-29 爱密斯菲尔科技公司 Compositions for delivering peptide yy and pyy agonists
NZ556373A (en) 2004-12-29 2010-01-29 Emisphere Tech Inc Pharmaceutical formulations of gallium salts
WO2006076692A1 (en) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
US20080153779A1 (en) * 2005-02-01 2008-06-26 Jun Liao Gastric Retention and Controlled Release Delivery System
WO2007011958A2 (en) 2005-07-15 2007-01-25 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
ATE552004T1 (en) 2005-11-30 2012-04-15 Istituto G Ronzoni ORAL HEPARINE DERIVATIVES
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2008003050A2 (en) 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
KR20090052346A (en) * 2006-09-12 2009-05-25 글락소 그룹 리미티드 Pharmaceutical composition comprising a plurality of small tablets comprising a factor XA inhibitor
US20110039930A1 (en) 2009-08-03 2011-02-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
RS56998B1 (en) 2010-12-16 2018-05-31 Novo Nordisk As Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
RU2602601C2 (en) 2011-04-12 2016-11-20 Ново Нордиск А/С Double acylated glp-1 derivatives
WO2013139695A1 (en) 2012-03-22 2013-09-26 Novo Nordisk A/S Compositions comprising a delivery agent and preparation thereof
TR201903918T4 (en) 2012-03-22 2019-04-22 Novo Nordisk As Compositions containing a dispersing agent and their preparation.
CN104203266B (en) 2012-03-22 2017-12-26 诺和诺德股份有限公司 GLP-1 peptide composition and its preparation
EP2863895B1 (en) 2012-06-20 2021-04-14 Novo Nordisk A/S Tablet formulation comprising a peptide and a delivery agent
RU2671406C2 (en) 2013-05-02 2018-10-31 Ново Нордиск А/С Oral dosing of glucagon-like peptide-1 compounds
IL303216A (en) 2015-02-09 2023-07-01 Entera Bio Ltd Treatment of hypoparathyroidism
JP7530173B2 (en) 2016-08-17 2024-08-07 エンテラ バイオ エルティーディー． Formulations for oral administration of active agents
BR112020014624A2 (en) 2018-02-02 2020-12-08 Novo Nordisk A/S SOLID COMPOSITIONS UNDERSTANDING GLP-1 AGONIST, CAPRILIC AND LUBRICANT N- (8- (2-HYDROXYBENZOIL) AMINO ACID SALT)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001347A (en) * 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents

Also Published As

Publication number Publication date
WO2000048589A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
AU3240900A (en) Solid oral dosage form containing heparin or a heparinoid in combination with a carrier
AU5259100A (en) Medicament
AU4939400A (en) Meter
AU3923700A (en) Dental materials
GB9930079D0 (en) Medicaments
GB9930071D0 (en) Medicaments
AU2692200A (en) Enteral sorbefacients
AU1645700A (en) Oenothein medicaments
HUP0202652A3 (en) Pharmaceutical carrier composition
GB9906149D0 (en) Polymer composition
GB9924990D0 (en) Medicaments
GB2349803B (en) Improvements in shelving
AU5442401A (en) Absorbent medicinal articles
GB9929040D0 (en) Medicaments
GB9930082D0 (en) Medicaments
GB9908613D0 (en) Mailing pack
GB9904935D0 (en) Medicaments
GB9912631D0 (en) Cell counter
HK1044801A1 (en) A blood detection composition
AU2077901A (en) Craze-resistant polymeric article
GB9929039D0 (en) Medicaments
AUPP458398A0 (en) Parcel delivery safe
GB9914316D0 (en) The forth millennium calculator
AUPP872799A0 (en) Improvements in packaging
AUPQ364499A0 (en) Improvements in locks

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase